Co-Culturing of Multipotent Mesenchymal Stromal Cells with Autological and Allogenic Lymphocytes

Bull Exp Biol Med. 2018 Mar;164(4):446-452. doi: 10.1007/s10517-018-4009-x. Epub 2018 Mar 4.

Abstract

We studied the effect of autologous and allogeneic lymphocytes on multipotent mesenchymal stromal cells in co-culture. It is shown that changes in multipotent mesenchymal stromal cells and in lymphocytes did not depend on the source of lymphocytes. Contact with lymphocytes triggers expression of HLA-DR molecules on multipotent mesenchymal stromal cells and these cells lose their immune privilege. In multipotent mesenchymal stromal cells, the relative level of expression of factors involved in immunomodulation (IDO1, PTGES, and IL-6) and expression of adhesion molecule ICAM1 increased, while expression of genes involved in the differentiation of multipotent mesenchymal stromal cells remained unchanged. Priming of multipotent mesenchymal stromal cells with IFN did not affect these changes. In turn, lymphocytes underwent activation, expression of HLA-DR increased, subpopulation composition of lymphocytes changed towards the increase in the content of naïve T cells. These findings are important for cell therapy.

Keywords: inhibition of lymphocyte proliferation; interferon gamma; major histocompatibility complex antigens; multipotent mesenchymal stromal cells; relative level of gene expression.

MeSH terms

  • Adolescent
  • Adult
  • Antigens, CD / genetics
  • Antigens, CD / immunology
  • Bone Marrow Cells / cytology
  • Bone Marrow Cells / drug effects
  • Bone Marrow Cells / immunology
  • CD4-Positive T-Lymphocytes / cytology
  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / immunology*
  • CD8-Positive T-Lymphocytes / cytology
  • CD8-Positive T-Lymphocytes / drug effects
  • CD8-Positive T-Lymphocytes / immunology*
  • Cell Communication / immunology*
  • Coculture Techniques
  • Female
  • Gene Expression Regulation / immunology*
  • HLA-DR Antigens / genetics
  • HLA-DR Antigens / immunology
  • Humans
  • Immunomodulation / drug effects
  • Immunophenotyping
  • Indoleamine-Pyrrole 2,3,-Dioxygenase / genetics
  • Indoleamine-Pyrrole 2,3,-Dioxygenase / immunology
  • Intercellular Adhesion Molecule-1 / genetics
  • Intercellular Adhesion Molecule-1 / immunology
  • Interferon-gamma / pharmacology
  • Interleukin-6 / genetics
  • Interleukin-6 / immunology
  • Lymphocyte Activation / drug effects
  • Male
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / drug effects
  • Mesenchymal Stem Cells / immunology*
  • Middle Aged
  • Phytohemagglutinins / pharmacology
  • Prostaglandin-E Synthases / genetics
  • Prostaglandin-E Synthases / immunology
  • Signal Transduction

Substances

  • Antigens, CD
  • HLA-DR Antigens
  • ICAM1 protein, human
  • IDO1 protein, human
  • IL6 protein, human
  • Indoleamine-Pyrrole 2,3,-Dioxygenase
  • Interleukin-6
  • Phytohemagglutinins
  • Intercellular Adhesion Molecule-1
  • Interferon-gamma
  • PTGES protein, human
  • Prostaglandin-E Synthases